Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,445.14 20.29 0.12%
S&P 500 1,866.94 4.63 0.25%
NASDAQ 4,106.25 20.02 0.49%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

Quest Diagnostics To Release Fourth Quarter And Full Year 2012 Financial Results On January 23

   Quest Diagnostics To Release Fourth Quarter And Full Year 2012 Financial
                            Results On January 23

PR Newswire

MADISON, N.J., Jan. 7, 2013

MADISON, N.J., Jan. 7, 2013 /PRNewswire/ -- Quest Diagnostics Incorporated
(NYSE: DGX), the world's leading provider of diagnostic information services,
announced that it will report fourth quarter and full year 2012 results and
provide financial guidance for 2013 on Wednesday, January 23, 2013 before the
market opens. It will hold its quarterly conference call to discuss the
results beginning at 8:30 a.m. Eastern Time on that day.

The conference call can also be accessed in listen-only mode by dialing
415-228-4961, passcode 3214469. The company suggests participants dial in
approximately 10 minutes before the call. 

A replay of the call may be accessed online at or by phone at 800-835-4610 for domestic
callers, or 203-369-3352 for international callers. Telephone replays will be
available from 10:30 a.m. Eastern Time on January 23 until midnight Eastern
Time on February 23, 2013.

Anyone listening to the call is encouraged to read the company's periodic
reports, on file with the Securities and Exchange Commission, including the
discussion of risk factors and historical results of operations and financial
condition in those reports.

Quest Diagnostics is the world's leading provider of diagnostic
information services that patients and doctors need to make better healthcare
decisions. The company offers the broadest access to diagnostic testing
services through its network of laboratories and patient service centers, and
provides interpretive consultation through its extensive medical and
scientific staff. Quest Diagnostics is a pioneer in developing innovative
diagnostic tests and advanced healthcare information technology solutions that
help improve patient care. Additional company information is available at

Kathleen Valentine (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800

SOURCE Quest Diagnostics Incorporated

Sponsored Links
Sponsored Links